XML 24 R14.htm IDEA: XBRL DOCUMENT
v3.23.1

Intangible Assets | 3 Months Ended
--- | ---
Apr. 01, 2023
Goodwill and Intangible Assets Disclosure [Abstract] |
Intangible Assets | Note 7: Intangible Assets Intangible assets as of April 1, 2023 and December 31, 2022 consist of the following (in $000’s):
|  | April 1, 2023 |  |  | December 31, 2022 |
Patent and domains |  | $ | 4 |  |  | $ | 4 |
Soin intangibles * |  | $ | 19,293 |  |  | $ | 19,293 |
Computer software |  |  | 3,563 |  |  |  | 3,563 |
Intangible assets from discontinued operations |  |  | — |  |  |  | 735 |
Intangible assets |  |  | 22,860 |  |  |  | 23,595 |
Less accumulated amortization |  |  | (3,926 | ) |  |  | (3,563 | )
Total intangible assets |  | $ | 18,934 |  |  | $ | 20,032 |
*The Soin intangibles acquired by the Company consist of the following: 1. Three pending patents related to the methods of using low-dose Naltrexone to treat chronic pain; 2. Final formula for Naltrexone; and 3. Orphan drug designation as approved by the FDA. Intangible amortization expense from continuing operations was $363,000 and $0 for the 13 weeks ended April 1, 2023 and April 2, 2022.

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for all or part of the information related to intangible assets. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -URI https://asc.fasb.org/subtopic&trid=2144471 + Details
Name: | us-gaap_IntangibleAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration